ER+/HER2+ Metastatic Breast Cancer
2 意见
• 07/03/23
0
0
嵌入
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论